Accepted (and Increased) Pharma Bid Roundup

Alexis Brekke Pellek PharmTech editorLast week’s post highlighted pharma deals that haven’t been working out due to rejected bids and stalled negotiations. On a more positive note, the past several months have also seen some successful acquisitions. This past week produced updates to some of Big Pharma’s pending pacts. Read more »

Sunshine in the Laboratory

Erik Greb PharmTech editor“The Physician Payments Sunshine Act” (see my previous post), introduced by Senators Chuck Grassley (R-IA) and Herb Kohl (D-WI), would require drug companies to disclose their payments to physicians. Besides showing how the pharmaceutical industry can influence the way doctors practice medicine, the act would also illustrate how industry payments might influence university research about drugs. Read more »

« Previous Page